Clinical Trials
All Clinical Trials - Page 49 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT00650546Phase 2/Phase 3Completed
Role of Exenatide in NASH-a Pilot Study
Exenatide
- NCT00544830Phase 2Active Not Recruiting
Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer
Gonadorelin
- NCT00832091Phase 2Completed
Study of Thymosin Beta 4 in Patients With Venous Stasis Ulcers
TB-500
- NCT00751790Phase 3Completed
Efficacy and Safety of a Triptorelin 6-month Formulation in Patients With Advanced Prostate Cancer
Gonadorelin
- NCT01516255Phase 1Completed
Effect of Liraglutide on Heart Frequency in Healthy Volunteers
Liraglutide
- NCT00776074Phase 2Completed
A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids.
Gonadorelin
- NCT00360334Phase 3Completed
A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With Minimum Weight Gain in Type 2 Diabetes Patients
Exenatide
- NCT00344851Phase 2Completed
Exenatide and Metformin Therapy in Overweight Women With PCOS
Exenatide
- NCT00382174Phase 2Completed
Study of Thymosin Beta 4 in Patients With Pressure Ulcers
TB-500
- NCT00433173N/ASuspended
Insulin Sensitivity in Men With the Metabolic Syndrome
Gonadorelin
- NCT00331851Phase 3Completed
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
Liraglutide
- NCT01518166Phase 1Completed
Effect of Liraglutide on Gastrointestinal Absorption of Several Drugs and Potential Influence of Liraglutide on Intragastric pH
Liraglutide
- NCT00318461Phase 3Completed
To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together
Liraglutide
- NCT00318422Phase 3Completed
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
Liraglutide
- NCT00333151Phase 3Completed
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
Liraglutide
- NCT00702520N/ACompleted
Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38833 (P05783)
Gonadorelin
- NCT00349557Phase 2Completed
Bevacizumab With Hormonal and Radiotherapy for High-Risk Prostate Cancer
Gonadorelin
- NCT00322348Phase 2Completed
Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-menopausal Women
Gonadorelin
- NCT01515579Phase 1Completed
Comparison of Two Liraglutide Formulations in Healthy Subjects
Liraglutide
- NCT00313001Phase 3Completed
Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.
Exenatide
- NCT00308139Phase 3Completed
Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)
Exenatide
- NCT00378690Phase 3Completed
A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARD
Gonadorelin
- NCT00329797Phase 3Completed
Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy
Gonadorelin
- NCT01507389Phase 1Completed
Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With Normal Liver Function
Liraglutide
- NCT00311766Phase 2Terminated
A Phase 2 Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
TB-500
- NCT00425256Phase 2Completed
Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD)
PT-141
- NCT00257712Phase 2Completed
SMART: Somatotrophics, Memory, and Aging Research Trial
Tesamorelin
- NCT00295750Phase 3Completed
The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer
Gonadorelin
- NCT00108732Phase 2Completed
A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer
Gonadorelin
- NCT00275262Phase 2Terminated
A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation
Gonadorelin
- NCT00294723Phase 3Terminated
To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1c
Liraglutide
- NCT00254254Phase 2Completed
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Exenatide in Adolescent Subjects With Type 2 Diabetes Mellitus
Exenatide
- NCT01424618N/AUnknown
A Novel Approach to Endometrial Preparation in Recipients of Donor Eggs
Gonadorelin
- NCT01515592Phase 1Completed
Safety and Tolerability of Liraglutide in Healthy Japanese Male Volunteers
Liraglutide
- NCT00324363Phase 3Completed
Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin
Exenatide
- NCT00267527Phase 2Terminated
A Study to Evaluate CJC 1295 in HIV Patients With Visceral Obesity
CJC-1295
- NCT00291616Phase 4Completed
Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis B
Thymosin-Alpha-1
- NCT02154139N/ACompleted
Leuprorelin Acetate SR 11.25 mg for Injection Specified Drug-use Survey "Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)"
Gonadorelin
- NCT00283062Phase 3Completed
Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy
Gonadorelin
- NCT00254397Phase 2Completed
Melanoma Vaccine With Peptides and Leuprolide
Gonadorelin
- NCT01511692Phase 1Completed
Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 Diabetes
Liraglutide
- NCT00254800Phase 1Completed
The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Females
Exenatide
- NCT02167893N/ACompleted
Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey "Long-term Use Survey in Prostate Cancer Patients (96 Weeks)"
Gonadorelin
- NCT00259896Phase 1Completed
In-patient Study in Patients With Type 2 Diabetes Mellitus
Exenatide
- NCT00135330Phase 3Completed
An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus
Exenatide
- NCT00241423Phase 2Completed
Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 Diabetes
Exenatide
- NCT00485537N/ACompleted
Pregnancy Outcomes With a GnRH Antagonist Protocol Versus GnRH-Agonist Protocol in ICSI Cycles
Gonadorelin
- NCT00417183Phase 4Unknown
Comparison of the Long GnRH Agonist Protocol and the Flexible GnRH Antagonist Protocol of Ovarian Stimulation
Gonadorelin
- NCT01613495N/AUnknown
Ghrelin Suppression by Octreotide in Prader-Willi
Ghrp-6
- NCT00375687N/AUnknown
Investigation of Early Hormonotherapy Efficacy of Prostate Cancer
Gonadorelin